• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Henry Schein (HSIC) Could Be 16% Undervalued On Higher Margin Growth Story

    Simply Wall St·10/27/2026 14:13:00
    Listen to the news

    Henry Schein (HSIC) is back in focus after recent trading left the stock modestly weaker over the past month while still showing a gain year to date. That split performance is drawing fresh attention.

    Recent trading suggests momentum in Henry Schein is cooling in the short term, with the 30 day share price return down 2.15% and the 90 day move slightly lower. At the same time, the year to date share price return of 10.01% and 1 year total shareholder return of 33% point to a stronger longer term trend that investors are weighing against current valuation.

    Scan how Henry Schein's recent momentum compares with a hand picked group of 30 resilient stocks with low risk scores that have weathered mixed market conditions with relatively steadier performance.

    So is Henry Schein’s recent pause a fair read on the underlying health care distribution and software business, or just sentiment cooling after a strong year to date move that now needs a valuation check?

    Most Popular Narrative: 14% Undervalued

    Against Henry Schein’s last close of $84.51, the most followed narrative pins fair value at $98.19. This frames recent share softness as a potential valuation mismatch rather than a clear signal of business fatigue.

    The company is experiencing strong growth in high-margin businesses such as Specialty Products, Technology, and private-label offerings. It expects over 50% of non-GAAP operating income to come from these segments, supporting structurally higher gross margins and likely driving earnings expansion.

    See why 6 investors see Henry Schein as 14% undervalued.

    Result: Fair Value of $98.19 (UNDERVALUED)

    Still, the Henry Schein story can break if equipment pricing pressure in areas like scanners erodes margins, or if the multi year analyst forecasts simply prove too optimistic.

    Find out about the key risks to this Henry Schein narrative.

    Next Steps

    If this mix of optimism and concern around Henry Schein feels familiar, do not sit on the sidelines and rely only on headlines. Go through the data, stress test the narratives, and weigh up the 3 key rewards and 1 important warning sign.

    Looking for more Henry Schein style investment ideas?

    If Henry Schein has sharpened your interest, do not stop at a single opportunity. Use the Simply Wall Street Screener to compare, contrast, and pressure test fresh ideas.